Nosology
Your CRO for CNS studies in the USA, Europe and Asia
GCT has truly extensive experience in CNS field. The table below reflects some experience examples we have had in the area. We effectively managed numerous trials in Alzheimer’s disease, Multiple Sclerosis, and Epilepsy in our regions. GCT’s core staff and top-management have Neurology and Psychiatry background which helps us maintain strong and solid relationships with KOLs and high-recruiting investigative sites.
Prospective subjects
Contract to FPI, days for regulatory approval
of global enrollment to clinical trials
country in EU by number of clinical trials
Power your CNS trials
GCT’s unrivaled team of experts is working alongside our customers to deliver new, better medicines to patients faster.
Click each area to learn more
Sleep
Neuromuscular Diseases
Neurology
Psychiatry
Neurodegenerative Diseases
Pain
Experience delivering decentralized and traditional clinical trials across neurology indications
Our experience spans all multiple sclerosis forms, rare and pediatric epilepsies and niche rare diseases. We have extensive expertise in neuroradiology and clinical outcomes scales and experience with wearables and digital biomarkers.
Phase I-IV multiple sclerosis studies delivered since 2001:
100
trials complete
100k+
Patients recruited
Sleep
Experience delivering decentralized and traditional clinical trials across neurology indications
Our experience spans all multiple sclerosis forms, rare and pediatric epilepsies and niche rare diseases. We have extensive expertise in neuroradiology and clinical outcomes scales and experience with wearables and digital biomarkers.
Phase I-IV multiple sclerosis studies delivered since 2001:
100
trials complete
100k+
Patients recruited
Neuromuscular Diseases
Experience delivering decentralized and traditional clinical trials across neurology indications
Our experience spans all multiple sclerosis forms, rare and pediatric epilepsies and niche rare diseases. We have extensive expertise in neuroradiology and clinical outcomes scales and experience with wearables and digital biomarkers.
Phase I-IV multiple sclerosis studies delivered since 2001:
100
trials complete
100k+
Patients recruited
Neurology
Experience delivering decentralized and traditional clinical trials across neurology indications
Our experience spans all multiple sclerosis forms, rare and pediatric epilepsies and niche rare diseases. We have extensive expertise in neuroradiology and clinical outcomes scales and experience with wearables and digital biomarkers.
Phase I-IV multiple sclerosis studies delivered since 2001:
100
trials complete
100k+
Patients recruited
Psychiatry
Experience delivering decentralized and traditional clinical trials across neurology indications1
Our experience spans all multiple sclerosis forms, rare and pediatric epilepsies and niche rare diseases. We have extensive expertise in neuroradiology and clinical outcomes scales and experience with wearables and digital biomarkers.
Phase I-IV multiple sclerosis studies delivered since 2001:
100
trials complete
100k+
Patients recruited
Neurodegenerative Diseases
Experience delivering decentralized and traditional clinical trials across neurology indications
Our experience spans all multiple sclerosis forms, rare and pediatric epilepsies and niche rare diseases. We have extensive expertise in neuroradiology and clinical outcomes scales and experience with wearables and digital biomarkers.
Phase I-IV multiple sclerosis studies delivered since 2001:
100
trials complete
100k+
Patients recruited
Pain
Meet our Experts
Jeffrey Apter,
MD
MD
President
With 30+ years of executive oversight, management and conducting experience in over 300 clinical trials in Eastern Europe, Russia and USA, 40+ years of practice in Psychiatry and Neurology, and dozens of publications, Dr. Apter has internationally renowned expertise in clinical research.
Being the founding member of numerous professional associations and research institutions, he has the knowledge, authority and enthusiasm to navigate clinical research programs in various regions and therapeutic areas.
With 30+ years of executive oversight, management and conducting experience in over 300 clinical trials in Eastern Europe, Russia and USA, 40+ years of practice in Psychiatry and Neurology, and dozens of publications, Dr. Apter has internationally renowned expertise in clinical research.
Being the founding member of numerous professional associations and research institutions, he has the knowledge, authority and enthusiasm to navigate clinical research programs in various regions and therapeutic areas.
With 30+ years of executive oversight, management and conducting experience in over 300 clinical trials in Eastern Europe, Russia and USA, 40+ years of practice in Psychiatry and Neurology, and dozens of publications, Dr. Apter has internationally renowned expertise in clinical research.
Being the founding member of numerous professional associations and research institutions, he has the knowledge, authority and enthusiasm to navigate clinical research programs in various regions and therapeutic areas.
With 30+ years of executive oversight, management and conducting experience in over 300 clinical trials in Eastern Europe, Russia and USA, 40+ years of practice in Psychiatry and Neurology, and dozens of publications, Dr. Apter has internationally renowned expertise in clinical research.
Being the founding member of numerous professional associations and research institutions, he has the knowledge, authority and enthusiasm to navigate clinical research programs in various regions and therapeutic areas.
Eugene Selivra,
MD
MD
President
With 30+ years of executive oversight, management and conducting experience in over 300 clinical trials in Eastern Europe, Russia and USA, 40+ years of practice in Psychiatry and Neurology, and dozens of publications, Dr. Apter has internationally renowned expertise in clinical research.
Being the founding member of numerous professional associations and research institutions, he has the knowledge, authority and enthusiasm to navigate clinical research programs in various regions and therapeutic areas.
With 30+ years of executive oversight, management and conducting experience in over 300 clinical trials in Eastern Europe, Russia and USA, 40+ years of practice in Psychiatry and Neurology, and dozens of publications, Dr. Apter has internationally renowned expertise in clinical research.
Case studies
GCT demonstrated strong therapeutic expertise and management’s capacity. GCT staff were very knowledgeable about the regulatory system in each country involved. They were able to offer the full support – from early feasibility and identification of the sites to implementation of the study. They are a hard-working group that produce results fast and deliver high quality work. They supported transparent and efficient team communication. All the important study updates were provided to us in a timely manner. The communication was always constructive and efficient, and solutions were offered for any issue encountered. 1
GCT demonstrated strong therapeutic expertise and management’s capacity. GCT staff were very knowledgeable about the regulatory system in each country involved. They were able to offer the full support – from early feasibility and identification of the sites to implementation of the study. They are a hard-working group that produce results fast and deliver high quality work. They supported transparent and efficient team communication. All the important study updates were provided to us in a timely manner. The communication was always constructive and efficient, and solutions were offered for any issue encountered.
CNS in blog
